Effect of Hepatitis G Virus Infection on Chronic Hepatitis C

Annals of Internal Medicine

Volumn 125, Issue 9, 1996, Pages 740-743

  Tanaka, Eiji ^b   Alter, Harvey J ^a   Nakatsuji, Yoshiyuki ^a   Shih, J Wai Kuo ^a   Kim, Jungsuh P ^c   Matsumoto, Akihiro ^b   Kobayashi, Masakazu ^b   Kiyosawa, Kendo ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Genelabs Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; VIRUS RNA;

ARTICLE; BLOOD; CHRONIC DISEASE; DRUG EFFECT; FLAVIVIRUS; GENETIC TRANSCRIPTION; HEPATITIS C; HUMAN; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; VIRUS HEPATITIS;

ANTIVIRAL AGENTS; CHRONIC DISEASE; FLAVIVIRIDAE; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERON-ALPHA; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, VIRAL; TRANSCRIPTION, GENETIC;

EID: 0030293542     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-9-199611010-00007     Document Type: Article

References (18)

1. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244:362-4.
2. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, et al. Detection of antibody to hepatitis C virus in prospectjvely followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989;321:1494-500.
3. Tanaka E, Kiyosawa K, Sodeyama T, Nakano Y, Yoshizawa K, Hayata T, et al. Significance of antibody to hepatitis C virus in Japanese patients with viral hepatitis: relationship between anti-HCV antibody and the prognosis of non-A, non-B post-transfusion hepatitis. J Med Virol. 1991;33:117-22.
4. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996;271:505-8.
5. Nakatsuji Y, Shih JW, Tanaka E, Kiyosawa K, Wages J Jr, Kim JP, et al. Prevalence and disease association of hepatitis G virus infection in Japan. J Viral Hepatol (In press).
6. Jeffers LJ, Piatak M, Bernstein DE, Reddy KR, Lifson JD, Yun A, et al. Hepatitis G virus infection in patients with acute and chronic liver disease of unknown etiology [Abstract]. Hepatology. 1996;22(4 Pt 2):182A.
7. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994; 19:1513-20.
8. Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. Viral and host factors that contribute to the efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C, Dig Dis Sci. 1994;39:1273-80.
9. Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-4.
10. Alter HJ, Sanchez-Pescador R, Urdea MS, Wilber JC, Lagier RJ, Di Bisceglie AM, et al. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat. 1995;2:121-32.
11. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 1992;73:673-9.
12. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechet C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes [Letter]. Hepatology. 1994;19:1321-4.
13. Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology. 1991;14:64-7.
14. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA. 1991;265:1974-6.
15. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology. 1993;105:1529-33.
16. Shindo M, Di Bisceglie AM, Cheung L, Shih WK, Cristiano K, Feinstone SM, et al. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med. 1991;115:700-4.
17. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology. 1992;16:293-9.
18. Tanaka E, Kiyosawa K, Matsumoto A, Kashiwakuma T, Hasegawa A, Mori H, et al. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa. Hepatology. 1996;23:1330-3.